Literature DB >> 22518841

Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein.

Mario Hebecker1, Mihály Józsi.   

Abstract

Human complement factor H-related protein (CFHR) 4 belongs to the factor H family of plasma glycoproteins that are composed of short consensus repeat (SCR) domains. Although factor H is a well known inhibitor of the alternative complement pathway, the functions of the CFHR proteins are poorly understood. CFHR4 lacks SCRs homologous to the complement inhibitory domains of factor H and, accordingly, has no significant complement regulatory activities. We have previously shown that CFHR4 binds C-reactive protein via its most N-terminal SCR, which leads to classical complement pathway activation. CFHR4 binds C3b via its C terminus, but the significance of this interaction is unclear. Therefore, we set out to clarify the functional relevance of C3b binding by CFHR4. Here, we report a novel role for CFHR4 in the complement system. CFHR4 serves as a platform for the assembly of an alternative pathway C3 convertase by binding C3b. This is based on the sustained ability of CFHR4-bound C3b to bind factor B and properdin, leading to an active convertase that generates C3a and C3b from C3. The CFHR4-C3bBb convertase is less sensitive to the factor H-mediated decay compared with the C3bBb convertase. CFHR4 mutants containing exchanges of conserved residues within the C-terminal C3b-binding site showed significantly reduced C3b binding and alternative pathway complement activation. In conclusion, our results suggest that, in contrast to the complement inhibitor factor H, CFHR4 acts as an enhancer of opsonization by promoting complement activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22518841      PMCID: PMC3365989          DOI: 10.1074/jbc.M112.364471

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  The central role of the alternative complement pathway in human disease.

Authors:  Joshua M Thurman; V Michael Holers
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

Review 2.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

3.  The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins.

Authors:  C Skerka; J Hellwage; W Weber; A Tilkorn; F Buck; T Marti; E Kampen; U Beisiegel; P F Zipfel
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

4.  An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).

Authors:  Lars G Fritsche; Nadine Lauer; Andrea Hartmann; Selina Stippa; Claudia N Keilhauer; Martin Oppermann; Manoj K Pandey; Jörg Köhl; Peter F Zipfel; Bernhard H F Weber; Christine Skerka
Journal:  Hum Mol Genet       Date:  2010-09-15       Impact factor: 6.150

5.  Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity.

Authors:  Josephine Losse; Peter F Zipfel; Mihály Józsi
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

6.  The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins.

Authors:  S Kühn; P F Zipfel
Journal:  Gene       Date:  1995-09-11       Impact factor: 3.688

7.  C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack.

Authors:  Leendert A Trouw; Anders A Bengtsson; Kyra A Gelderman; Björn Dahlbäck; Gunnar Sturfelt; Anna M Blom
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

8.  Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.

Authors:  Stefan Heinen; Andrea Hartmann; Nadine Lauer; Ulrike Wiehl; Hans-Martin Dahse; Sylvia Schirmer; Katharina Gropp; Tina Enghardt; Reinhard Wallich; Steffi Hälbich; Michael Mihlan; Ursula Schlötzer-Schrehardt; Peter F Zipfel; Christine Skerka
Journal:  Blood       Date:  2009-06-15       Impact factor: 22.113

9.  Structural basis for engagement by complement factor H of C3b on a self surface.

Authors:  Hugh P Morgan; Christoph Q Schmidt; Mara Guariento; Bärbel S Blaum; Dominic Gillespie; Andrew P Herbert; David Kavanagh; Haydyn D T Mertens; Dmitri I Svergun; Conny M Johansson; Dušan Uhrín; Paul N Barlow; Jonathan P Hannan
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

10.  The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Authors:  Viviana P Ferreira; Andrew P Herbert; Claudio Cortés; Kristi A McKee; Bärbel S Blaum; Stefan T Esswein; Dusan Uhrín; Paul N Barlow; Michael K Pangburn; David Kavanagh
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

View more
  39 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  FHR4-based immunoconjugates direct complement-dependent cytotoxicity and phagocytosis towards HER2-positive cancer cells.

Authors:  Carole Seguin-Devaux; Jean-Marc Plesseria; Charlène Verschueren; Cécile Masquelier; Gilles Iserentant; Marie Fullana; Mihály Józsi; Jacques H M Cohen; Xavier Dervillez
Journal:  Mol Oncol       Date:  2019-09-30       Impact factor: 6.603

3.  Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.

Authors:  Nirmal K Banda; Gaurav Mehta; Viviana P Ferreira; Claudio Cortes; Matthew C Pickering; Michael K Pangburn; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2013-02-22       Impact factor: 5.422

4.  A novel, multiplexed targeted mass spectrometry assay for quantification of complement factor H (CFH) variants and CFH-related proteins 1-5 in human plasma.

Authors:  Pingbo Zhang; Min Zhu; Minghui Geng-Spyropoulos; Michelle Shardell; Marta Gonzalez-Freire; Vilmundur Gudnason; Gudny Eiriksdottir; Debra Schaumberg; Jennifer E Van Eyk; Luigi Ferrucci; Richard D Semba
Journal:  Proteomics       Date:  2017-03       Impact factor: 3.984

5.  Dimerization of complement factor H-related proteins modulates complement activation in vivo.

Authors:  Elena Goicoechea de Jorge; Joseph J E Caesar; Talat H Malik; Mitali Patel; Matthew Colledge; Steven Johnson; Svetlana Hakobyan; B Paul Morgan; Claire L Harris; Matthew C Pickering; Susan M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

Review 6.  The role of the alternative pathway of complement activation in glomerular diseases.

Authors:  Emilia Łukawska; Magdalena Polcyn-Adamczak; Zofia I Niemir
Journal:  Clin Exp Med       Date:  2018-02-15       Impact factor: 3.984

7.  C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.

Authors:  Agustín Tortajada; Hugo Yébenes; Cynthia Abarrategui-Garrido; Jaouad Anter; Jesús M García-Fernández; Rubén Martínez-Barricarte; María Alba-Domínguez; Talat H Malik; Rafael Bedoya; Rocío Cabrera Pérez; Margarita López Trascasa; Matthew C Pickering; Claire L Harris; Pilar Sánchez-Corral; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

Review 8.  Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus.

Authors:  Brendan M Giles; Susan A Boackle
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

Review 9.  Genetic variants in the complement system predisposing to age-related macular degeneration: a review.

Authors:  Elizabeth C Schramm; Simon J Clark; Michael P Triebwasser; Soumya Raychaudhuri; Johanna Seddon; John P Atkinson
Journal:  Mol Immunol       Date:  2014-07-15       Impact factor: 4.407

10.  Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.

Authors:  Simon J Clark; Christoph Q Schmidt; Anne M White; Svetlana Hakobyan; B Paul Morgan; Paul N Bishop
Journal:  J Immunol       Date:  2014-10-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.